Absorption of intramuscular phenobarbitone in children with severe falciparum malaria
- 16 Downloads
The absorption of intramuscular phenobarbitone 7 mg·kg−1 was studied in 11 Karen children aged between 1.7 and 11 y with severe falciparum malaria. Eight of the children were comatose. Clinical findings were compared with those in 9 further children with severe malaria of similar age range (four of whom were unconscious), who received an identical placebo. One child, who had received placebo, had repeated convulsions and died 1 h after admission to hospital. The remainder made an uncomplicated recovery. There were no convulsions subsequent to treatment, although the study was too small to assess anticonvulsant efficacy. There was no observable toxicity, but phenobarbitone recipients had a significant tendency to deepen in their level of coma or to become sleepy within the 4 h after drug administration. Phenobarbitone was rapidly absorbed, reaching a mean (range) peak concentration of 34.2 [29.3–42.6] μmol·l−1 in a median (range) of 4 (2.5–12) h. These values are comparable to those previously reported in healthy children and in children with febrile convulsions. Intramuscular phenobarbitone is well absorbed in children with severe malaria; the optimum prophylactic anticonvulsant dose remains to be determined.
Key wordsPhenobarbitone Cerebral malaria P.falciparum kinetics drug absorption children
Unable to display preview. Download preview PDF.
- Brachet-Liermain A, Goutieres F, Aicardi J (1975) Absorption of phenobarbital after the intramuscular administration of single doses in infants. J Pediatr 87: 624–626Google Scholar
- Brewster D, Kwiatkowski D, White NJ (1990) Neurological sequelae of cerebral malaria in childhood. Lancet II: 1039–1043Google Scholar
- Clayton BE, Round JM (1984) Chemical pathology and the sick child. Blackwell, Oxford, p 422Google Scholar
- Molyneux M, Taylor TE, Wirima JJ, Borgstein A (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71: 441–459Google Scholar
- Nosten F, Imvithaya S, Vincenti M, Delmas G, Lebihan G, Hausler B, White NJ (1987) Malaria on the Thai-Burmese border; treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine combination. Bull WHO 65: 891–896Google Scholar
- Pearce JL, Sharman JR, Forster RM (1977) Phenobarbital in the acute management of febrile convulsions. Pediatrics 60: 569–572Google Scholar
- Waller D, Krishna S, Craddock C, Brewster D, Jammeh A, Kwiatkowski D, Karbwang J, Molunto P, White NJ (1990) The pharmacokinetic properties of intramuscular quinine in Gambian children with severe falciparum malaria. Trans R Soc Trop Med Hyg 84: 488–491Google Scholar
- White NJ (1986) Pathophysiology in clinics in tropical medicine and communicable disease, vol 1. Malaria. In: Strickland GT (ed) Pathophysiology. Saunders, London, pp 55–90Google Scholar
- White NJ, Looareesuwan S, Chanthavanich P, Phillips RE, Warrell DA (1988) Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet II: 64–66Google Scholar
- World Health Organization (1990) Severe and complicated malaria. Trans R Soc Trop Med Hyg 84 [Suppl 2]: 1–65Google Scholar